[1]
Trave, I. et al. 2024. Tralokinumab as an Alternative to Dupilumab in a Patient with Atopic Dermatitis and Asthma who Developed Hypereosinophilia: A Case Report. Acta Dermato-Venereologica. 104, (Sep. 2024), adv40800. DOI:https://doi.org/10.2340/actadv.v104.40800.